CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Circulating Tumor DNA Dynamics and Treatment Outcome of Regorafenib in Metastatic Colorectal Cancer
Dae-Won Lee, Yoojoo Lim, Hwang-Phill Kim, Su Yeon Kim, Hanseong Roh, Jun-Kyu Kang, Kyung‑Hun Lee, Min Jung Kim, Seung-Bum Ryoo, Ji Won Park, Seung-Yong Jeong, Kyu Joo Park, Gyeong Hoon Kang, Sae-Won Han, Tae-You Kim
Cancer Research and Treatment. 2023;55(3):927-938.   Published online 2023 March 7    DOI:

Excel Download

Circulating Tumor DNA Dynamics and Treatment Outcome of Regorafenib in Metastatic Colorectal Cancer
Cancer Research and Treatment. 2023;55(3):927-938   Crossref logo
Link1 Link2 Link3

Parallel Evaluation of Circulating Tumor DNA and Circulating Tumor Cells in Metastatic Colorectal Cancer
Clinical Colorectal Cancer. 2018;17(1):80-83   Crossref logo
Link1 Link2

2013 Analysis of biomarkers in circulating tumor DNA from the phase 3 CONCUR study of regorafenib in Asian patients with metastatic colorectal cancer (mCRC): Correlation with clinical outcome
European Journal of Cancer. 2015;51:S332   Crossref logo
Link1 Link2

Circulating DNA and Protein Biomarkers for the Treatment of Metastatic Colorectal Cancer with Tyrosine Kinase Inhibitors
Oncogenomics. 2019;271-285   Crossref logo
Link1 Link2

386P Methylated circulating tumor DNA in plasma as a biomarker for treatment efficacy in metastatic colorectal cancer
Annals of Oncology. 2022;33:S713   Crossref logo
Link1 Link2

Clinical Utility of Analyzing Circulating Tumor DNA in Patients with Metastatic Colorectal Cancer
The Oncologist. 2018;23(11):1310-1318   Crossref logo
Link1 Link2 Link3 Link4

Circulating Tumor Cells Versus Circulating Tumor DNA in Colorectal Cancer: Pros and Cons
Current Colorectal Cancer Reports. 2016;12(3):151-161   Crossref logo
Link1 Link2 Link3

Predictive Value of Early Tumor Shrinkage and Density Reduction of Lung Metastases in Patients With Metastatic Colorectal Cancer Treated With Regorafenib
Clinical Colorectal Cancer. 2017;16(4):377-380   Crossref logo
Link1 Link2

Regorafenib and Nivolumab or Pembrolizumab Combination and Circulating Tumor DNA Response Assessment in Refractory Microsatellite Stable Colorectal Cancer
The Oncologist. 2020;25(8):e1188-e1194   Crossref logo
Link1 Link2 Link3 Link4 Link5

Correction to: Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA
Targeted Oncology. 2021;16(3):413-413   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.